rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

LifeMD, Inc.

LFMD · Nasdaq

Health CareDigital Health & TelemedicineNot moving yetGLP-1

LFMD stood above a rising 150-day average in 2 of the last 52 weekly readings, and has been out of that trend for the last 13 weeks. It is 39.8% below that average now. Digital Health & Telemedicine: 20% of its 5 stocks in an uptrend (±0 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 13
Industry in uptrend
20% 0 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$54K
Officials’ trades on record
0
Institutions holding
110 (+14)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 2 of 52 weeks.

17 Apr – 16 Oct
1%20%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Digital Health & Telemedicine: A minority of its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$3.1M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months1
Buyers · sellers0 · 1

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders110+14 on the quarter
New · exited26 · 11
Reported value$89.2M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20263,034,535$12.5M+225,510+8.0%
FEDERATED HERMES, INC.added · filed 12 Aug 20262,747,655$11.3M+1,728,578+169.6%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20261,734,756$7.2M+71,060+4.3%
STATE STREET CORPadded · filed 7 Aug 20261,318,784$5.4M+243,376+22.6%
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 20261,079,525$4.5M-38,800−3.5%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20261,067,698$4.4M+48,257+4.7%
Prescott Group Capital Management, L.L.C.added · filed 7 Aug 2026897,224$3.7M+1,800+0.2%
BRC Group Holdings, Inc.reduced · filed 14 Aug 2026637,319$2.6M-234,261−26.9%
ROYCE & ASSOCIATES LPreduced · filed 14 Aug 2026636,124$2.6M-565,527−47.1%
AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026619,506$2.6M+421,184+212.4%
31 Mar 2023 – 30 Jun 2026
3675113Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Calum Archibald Macrae Company insiderDirector · last 11 Aug 20260 · 0
Joan Larovere Company insiderDirector · last 11 Aug 20260 · 0
John R. Strawn Jr. Company insiderDirector · last 11 Aug 20260 · 0
Joseph DiTrolio Company insiderDirector · last 11 Aug 20265 · 0
Roberto Simon Company insiderDirector · last 11 Aug 20260 · 0
Umesh Sripad Company insiderChief Technology Officer · last 1 Jun 20260 · 0
Atul Kavthekar Company insiderChief Financial Officer · last 11 May 20260 · 0
Christopher A. Pisano Company insiderChief Marketing Officer · last 30 Mar 20260 · 0
Jessica Friedeman Company insiderChief Marketing Officer · last 9 Dec 20250 · 2
Nicholas P. Alvarez Company insiderChief Acquisition Officer · last 10 Sep 20251 · 1
Dennis Wijnker Company insiderChief Technology Officer · last 22 Aug 20250 · 0
Eric Harold Yecies Company insiderChief Legal Officer & GC · last 22 Aug 20255 · 1

Same industry

DOCS DoximityJust started moving+30%
PHR PhreesiaAbove a falling average+7%
TDOC Teladoc HealthNot moving yet-16%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202585.7%
Operating profit marginFY 2025 · to 31 Dec 2025-4.0%
Free cash flow marginFY 2025 · to 31 Dec 20253.3%
Return on capital employedFY 2025 · to 31 Dec 2025-26.6%
Cash conversionFY 2025 · to 31 Dec 202557.7%
Interest coverFY 2025 · to 31 Dec 2025-5.64×
Share count trendFY 2025 · to 9 Mar 20262.8%
Cash and equivalentsFY 2025 · to 31 Dec 2025$36.8M
Free cash flowFY 2025 · to 31 Dec 2025$6.4M

Analyst forecasts

No analyst forecasts yet.